Biospace
Published October 7, 2026
Kalohexis Announces Poster Presentation at ObesityWeek® 2026 Annual Meeting
Read the full story at Biospace
NORTHBROOK, Ill., Oct. 7, 2026/PRNewswire/ -- Kalohexis, Inc., a clinical-stage biotechnology company harnessing the melanocortin system to shape the.
Surfaced by this Google Alert
- Psychedelic biotech